ArticleScientific reports2026
Association between HALP score and in-hospital outcomes in patients with acute kidney injury: a retrospective cohort study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Acute kidney injury (AKI) is a prevalent clinical syndrome among hospitalized patients, affecting 20-30% of inpatients, with mortality rates exceeding 50% in ICU settings. The HALP score (hemoglobin, albumin, lymphocyte, and platelet), a composite biomarker reflecting inflammatory and nutritional status, has shown prognostic value across various conditions, while the application of the HALP score in AKI remains underexplored. In this study, a total of 1,005 patients with AKI were included. Fine-Gray competing risk models were employed for the primary analysis, with the robustness of the findings assessed through cumulative incidence function (CIF) curves and sensitivity analyses. After adjusting for confounders, a higher HALP score was significantly associated with partial recovery and complete recovery. The Q4 group also demonstrated the lowest cumulative risk of therapy cessation (Day 21: 11.0%), with significantly reduced risks observed in Q3 (SHR 0.66) and Q4 (SHR 0.39). Taken together, the HALP score is significantly associated with renal recovery and therapy cessation in patients with AKI and may serve as a convenient tool for risk stratification, thereby complementing personalized treatment decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.